Covid-19 Vaccine: UK Experts Caution Against Hopes Of ‘Return To Normal’
Distribution of Pfizer/BioNTech Vaccine Will Be A ‘Mammoth’ Logistical Operation
The Pfizer/BioNTech coronavirus vaccine results are a cause for celebration, but there is still a long way to go. Safety data are still awaited, as is more information on efficacy, and the mass rollout of the vaccine will pose significant practical challenges.
